SEC Tracker
Get the app
Person · CIK 1974200

Jolanda Howe

SVP at Mirum Pharmaceuticals

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$9.3M
Noticed on Form 144$8.6M
Bought on Form 4$0
Companies1

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Mirum Pharmaceuticals MIRMCommon StockDirectly16,728Oct 16, 2026 · Filing · EDGAR
Mirum Pharmaceuticals MIRMEmployee Stock Option (right to buy)
exercise $19.24, expires Jan 9, 2030, into Common Stock
Directly8,888Oct 16, 2026 · Filing · EDGAR

Sold and noticed by quarter

Jolanda Howe: dollars sold on Form 4 and noticed on Form 144 per quarter, Q3 2023 to Q4 2026$4.6M$0Q3 2023: $0 noticed on Form 144Q3 2023: $114K sold on Form 4Q4 2023: $0 noticed on Form 144Q4 2023: $81K sold on Form 4Q1 2024: $0 noticed on Form 144Q1 2024: $34K sold on Form 4Q2 2024: $0 noticed on Form 144Q2 2024: $0 sold on Form 4Q3 2024: $0 noticed on Form 144Q3 2024: $13K sold on Form 4Q4 2024: $0 noticed on Form 144Q4 2024: $118K sold on Form 4Q1 2025: $2.5M noticed on Form 144Q1 2025: $2.8M sold on Form 4Q2 2025: $0 noticed on Form 144Q2 2025: $0 sold on Form 4Q3 2025: $603K noticed on Form 144Q3 2025: $631K sold on Form 4Q4 2025: $0 noticed on Form 144Q4 2025: $0 sold on Form 4Q1 2026: $620K noticed on Form 144Q1 2026: $703K sold on Form 4Q2 2026: $264K noticed on Form 144Q2 2026: $264K sold on Form 4Q3 2026: $4.6M noticed on Form 144Q3 2026: $4.6M sold on Form 4Q4 2026: $0 noticed on Form 144Q4 2026: $0 sold on Form 4Q3 2023Q2 2024Q1 2025Q4 2025Q3 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)
Q3 2026$4.6M$4.6M
Q2 2026$264K$264K
Q1 2026$703K$620K
Q3 2025$631K$603K
Q1 2025$2.8M$2.5M
Q4 2024$118K—
Q3 2024$13K—
Q1 2024$34K—
Q4 2023$81K—
Q3 2023$114K—

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice dateNoticedPlanned saleOutcomeLinks
Mirum Pharmaceuticals MIRM · Morgan Stanley Smith Barney · 10b5-1 plan adopted Mar 18, 2026 · 4 notices
Sep 2, 2026658 · ~$66KSep 2, 2026Sold as noticed Sold 658 at $100.00 on Sep 2 · $66K Form 4Filing · EDGAR
Aug 3, 20261,840 · ~$194KAug 3, 2026Sold as noticed Sold 1,840 at $105.29 on Aug 3 · $194K Form 4Filing · EDGAR
Jul 1, 20262,721 · ~$327KJul 1, 2026Sold as noticed Sold 2,721 at $120.00 on Jul 1 · $327K Form 4Filing · EDGAR
Jun 17, 20262,594 · ~$264KJun 17, 2026Sold as noticed Sold 2,594 at $101.95 on Jun 17 · $264K Form 4Filing · EDGAR
Mirum Pharmaceuticals MIRM · Morgan Stanley Smith Barney · No 10b5-1 plan stated · 1 notice
Aug 18, 202640,000 · ~$4MAug 18, 2026Sold as noticed Sold 40,000 at $100.00 on Aug 18 · $4M Form 4Filing · EDGAR
Mirum Pharmaceuticals MIRM · Morgan Stanley Smith Barney · 10b5-1 plan adopted Jan 31, 2023 · 2 notices
Mar 17, 20264,732 · ~$438KMar 16, 2026Sold as noticed Sold 4,732 at $91.98 on Mar 16 · $435K Form 4Filing · EDGAR
Feb 2, 2026968 · ~$100KFeb 2, 2026Sold as noticed Sold 968 at $103.30 on Feb 2 · $100K Form 4Filing · EDGAR
Mirum Pharmaceuticals MIRM · Morgan Stanley Smith Barney · 10b5-1 plan adopted Jan 23, 2024 · 1 notice
Jan 28, 2026842 · ~$82KJan 26, 2026Sold as noticed Sold 842 at $96.19 on Jan 26 · $81K Form 4Filing · EDGAR
Mirum Pharmaceuticals MIRM · Morgan Stanley Smith Barney · 10b5-1 plan adopted Dec 16, 2024 · 4 notices
Aug 7, 202510,000 · ~$580KAug 7, 2025Sold as noticed Sold 10,000 at $58.00 on Aug 7 · $580K Form 4Filing · EDGAR
Jul 3, 2025477 · ~$23KJul 3, 2025Sold as noticed Sold 477 at $49.08 on Jul 3 · $23K Form 4Filing · EDGAR
Mar 18, 20252,415 · ~$107KMar 18, 2025Sold as noticed Sold 2,415 at $44.45 on Mar 18 · $107K Form 4Filing · EDGAR
Mar 17, 202554,706 · ~$2.4MMar 17, 2025Sold as noticed Sold 54,817 in 3 sales, Mar 17 to Mar 17 · $2.4M Form 4Filing · EDGAR
Sales without a matching Form 144 · 13 sales
No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
———Sold without notice Mirum Pharmaceuticals (MIRM): Sold 926 at $93.33 on Jan 22, 2026 · $86KFiling · EDGAR
———Sold without notice Mirum Pharmaceuticals (MIRM): Sold 564 at $48.25 on Jul 2, 2025 · $27K (10b5-1 plan)Filing · EDGAR
———Sold without notice Mirum Pharmaceuticals (MIRM): Sold 2,789 at $44.75 on Mar 17, 2025 · $125K (10b5-1 plan)Filing · EDGAR
———Sold without notice Mirum Pharmaceuticals (MIRM): Sold 1,064 at $48.22 on Feb 3, 2025 · $51KFiling · EDGAR
———Sold without notice Mirum Pharmaceuticals (MIRM): Sold 902 at $47.92 on Jan 24, 2025 · $43KFiling · EDGAR
———Sold without notice Mirum Pharmaceuticals (MIRM): Sold 750 at $42.82 on Jan 7, 2025 · $32KFiling · EDGAR
———Sold without notice Mirum Pharmaceuticals (MIRM): Sold 2,500 at $47.10 on Nov 14, 2024 · $118KFiling · EDGAR
———Sold without notice Mirum Pharmaceuticals (MIRM): Sold 375 at $34.00 on Jul 2, 2024 · $13KFiling · EDGAR
———Sold without notice Mirum Pharmaceuticals (MIRM): Sold 735 at $26.19 on Feb 2, 2024 · $19KFiling · EDGAR
———Sold without notice Mirum Pharmaceuticals (MIRM): Sold 528 at $28.04 on Jan 8, 2024 · $15KFiling · EDGAR
———Sold without notice Mirum Pharmaceuticals (MIRM): Sold 2,500 at $32.40 on Dec 5, 2023 · $81KFiling · EDGAR
———Sold without notice Mirum Pharmaceuticals (MIRM): Sold 3,459 at $26.23 on Aug 25, 2023 · $91KFiling · EDGAR
———Sold without notice Mirum Pharmaceuticals (MIRM): Sold 915 at $25.65 on Jul 3, 2023 · $23KFiling · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Mirum Pharmaceuticals MIRM SVP, global controller · filings 2023 to 2026 · sold $9.3M · $8.6M noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
Oct 16, 2026Option or RSU exercised or converted+16,112$19.24$310K16,728 directFiling · EDGAR
Oct 16, 2026Option or RSU exercised or converted
Employee Stock Option (right to buy)
−16,1128,888 directFiling · EDGAR
Sep 2, 2026Sale under a 10b5-1 plan−658$100.00$66K616 directFiling · EDGAR
Aug 18, 2026Option or RSU exercised or converted+40,000$6.27$251K41,274 directFiling · EDGAR
Aug 18, 2026Open-market or private sale−40,000$100.00$4M1,274 directFiling · EDGAR
Aug 18, 2026Option or RSU exercised or converted
Employee Stock Option (right to buy)
−40,0000 directFiling · EDGAR
Aug 3, 2026Sale under a 10b5-1 plan−1,840$105.29$194K1,274 directFiling · EDGAR
Jul 1, 2026Sale under a 10b5-1 plan−2,721$120.00$327K3,114 directFiling · EDGAR
Jun 17, 2026Sale under a 10b5-1 plan−2,594$101.95$264K5,835 directFiling · EDGAR
Mar 16, 2026Open-market or private sale−4,732$91.98$435K8,429 directFiling · EDGAR
Mar 15, 2026Option or RSU exercised or converted+2,6587,161 directFiling · EDGAR
Mar 15, 2026Option or RSU exercised or converted+6,00013,161 directFiling · EDGAR
Mar 15, 2026Option or RSU exercised or converted
Performance Restricted Stock Units
−2,6580 directFiling · EDGAR
Mar 15, 2026Option or RSU exercised or converted
Performance Restricted Stock Units
−6,0003,000 directFiling · EDGAR
Feb 2, 2026Open-market or private sale−968$103.30$100K4,503 directFiling · EDGAR
Jan 31, 2026Option or RSU exercised or converted+1,7715,471 directFiling · EDGAR
Jan 31, 2026Option or RSU exercised or converted
Restricted Stock Units
−1,7710 directFiling · EDGAR
Jan 28, 2026Grant or award from the company
Stock Option (right to buy)
+7,6807,680 directFiling · EDGAR
Jan 28, 2026Grant or award from the company
Restricted Stock Units
+4,9704,970 directFiling · EDGAR
Jan 28, 2026Grant or award from the company
Performance Restricted Stock Units
+9,0009,000 directFiling · EDGAR
Jan 26, 2026Open-market or private sale−842$96.19$81K3,700 directFiling · EDGAR
Jan 23, 2026Option or RSU exercised or converted+1,5004,542 directFiling · EDGAR
Jan 23, 2026Option or RSU exercised or converted
Restricted Stock Units
−1,5001,500 directFiling · EDGAR
Jan 22, 2026Open-market or private sale−926$93.33$86K3,042 directFiling · EDGAR
Jan 21, 2026Option or RSU exercised or converted+1,5423,968 directFiling · EDGAR
Jan 21, 2026Option or RSU exercised or converted
Restricted Stock Units
−1,5423,083 directFiling · EDGAR
Aug 7, 2025Option or RSU exercised or converted+10,000$6.27$63K12,426 directFiling · EDGAR
Aug 7, 2025Sale under a 10b5-1 plan−10,000$58.00$580K2,426 directFiling · EDGAR
Aug 7, 2025Option or RSU exercised or converted
Employee Stock Option (right to buy)
−10,00040,000 directFiling · EDGAR
Jul 3, 2025Sale under a 10b5-1 plan−477$49.08$23K2,426 directFiling · EDGAR
Jul 2, 2025Sale under a 10b5-1 plan−564$48.25$27K2,903 directFiling · EDGAR
Jul 1, 2025Option or RSU exercised or converted+1,0413,467 directFiling · EDGAR
Jul 1, 2025Option or RSU exercised or converted
Restricted Stock Units
−1,0410 directFiling · EDGAR
Mar 18, 2025Sale under a 10b5-1 plan−2,415$44.45$107K2,426 directFiling · EDGAR
Mar 17, 2025Sale under a 10b5-1 plan−2,900$44.21$128K6,647 directFiling · EDGAR
Mar 17, 2025Option or RSU exercised or converted+52,900$2.94$156K59,547 directFiling · EDGAR
Mar 17, 2025Sale under a 10b5-1 plan−50,111$44.33$2.2M9,436 directFiling · EDGAR
Mar 17, 2025Sale under a 10b5-1 plan−2,789$44.75$125K6,647 directFiling · EDGAR
Mar 17, 2025Sale under a 10b5-1 plan−1,806$44.36$80K4,841 directFiling · EDGAR
Mar 17, 2025Option or RSU exercised or converted
Stock Option (right to buy)
−52,9000 directFiling · EDGAR
Mar 15, 2025Option or RSU exercised or converted+5,3159,547 directFiling · EDGAR
Mar 15, 2025Option or RSU exercised or converted
Performance Restricted Stock Units
−5,3152,658 directFiling · EDGAR
Feb 3, 2025Open-market or private sale−1,064$48.22$51K4,232 directFiling · EDGAR
Jan 31, 2025Option or RSU exercised or converted+1,7725,296 directFiling · EDGAR
Jan 31, 2025Option or RSU exercised or converted
Restricted Stock Units
−1,7721,771 directFiling · EDGAR
Jan 24, 2025Open-market or private sale−902$47.92$43K3,524 directFiling · EDGAR
Jan 23, 2025Option or RSU exercised or converted+1,5004,426 directFiling · EDGAR
Jan 23, 2025Option or RSU exercised or converted
Restricted Stock Units
−1,5003,000 directFiling · EDGAR
Jan 21, 2025Grant or award from the company
Stock Option (right to buy)
+18,50018,500 directFiling · EDGAR
Jan 21, 2025Grant or award from the company
Restricted Stock Units
+4,6254,625 directFiling · EDGAR
Jan 21, 2025Grant or award from the company
Performance Restricted Stock Units
+7,9737,973 directFiling · EDGAR
Jan 7, 2025Open-market or private sale−750$42.82$32K2,926 directFiling · EDGAR
Jan 6, 2025Option or RSU exercised or converted+1,2503,676 directFiling · EDGAR
Jan 6, 2025Option or RSU exercised or converted
Restricted Stock Units
−1,2500 directFiling · EDGAR
Nov 14, 2024Option or RSU exercised or converted+2,500$2.94$7K4,926 directFiling · EDGAR
Nov 14, 2024Open-market or private sale−2,500$47.10$118K2,426 directFiling · EDGAR
Nov 14, 2024Option or RSU exercised or converted
Stock Option (right to buy)
−2,50052,900 directFiling · EDGAR
Jul 2, 2024Open-market or private sale−375$34.00$13K2,426 directFiling · EDGAR
Jul 1, 2024Option or RSU exercised or converted+1,0422,801 directFiling · EDGAR
Jul 1, 2024Option or RSU exercised or converted
Restricted Stock Units
−1,0421,041 directFiling · EDGAR

17 earlier transactions are in the filing list below.

All 40 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Oct 19, 2026Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Sep 3, 2026Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Sep 2, 2026Form 144Mirum Pharmaceuticals MIRMFiling · EDGAR
Aug 19, 2026Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Aug 18, 2026Form 144Mirum Pharmaceuticals MIRMFiling · EDGAR
Aug 5, 2026Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Aug 3, 2026Form 144Mirum Pharmaceuticals MIRMFiling · EDGAR
Jul 2, 2026Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Jul 1, 2026Form 144Mirum Pharmaceuticals MIRMFiling · EDGAR
Jun 18, 2026Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Jun 17, 2026Form 144Mirum Pharmaceuticals MIRMFiling · EDGAR
Mar 17, 2026Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Mar 17, 2026Form 144Mirum Pharmaceuticals MIRMFiling · EDGAR
Feb 3, 2026Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Feb 2, 2026Form 144Mirum Pharmaceuticals MIRMFiling · EDGAR
Jan 30, 2026Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Jan 28, 2026Form 144Mirum Pharmaceuticals MIRMFiling · EDGAR
Jan 27, 2026Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Jan 23, 2026Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Aug 8, 2025Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Aug 7, 2025Form 144Mirum Pharmaceuticals MIRMFiling · EDGAR
Jul 3, 2025Form 144Mirum Pharmaceuticals MIRMFiling · EDGAR
Jul 3, 2025Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Mar 19, 2025Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Mar 18, 2025Form 144Mirum Pharmaceuticals MIRMFiling · EDGAR
Mar 18, 2025Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Mar 17, 2025Form 144Mirum Pharmaceuticals MIRMFiling · EDGAR
Feb 4, 2025Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Jan 27, 2025Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Jan 23, 2025Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Jan 8, 2025Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Nov 15, 2024Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Jul 3, 2024Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Feb 2, 2024Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Jan 25, 2024Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Jan 9, 2024Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Dec 6, 2023Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Aug 28, 2023Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
Jul 5, 2023Form 4Mirum Pharmaceuticals MIRMFiling · EDGAR
May 9, 2023Form 3Mirum Pharmaceuticals MIRMFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.